TRILTrillium Therapeutics Inc


$ 18.45 $ 0.47 (2.62 %)    

Tuesday, 16-Nov-2021 15:59:58 EST
QQQ $ 454.82 $ 0.74 (0.16 %)
DIA $ 398.57 $ -1.41 (-0.36 %)
SPY $ 530.36 $ -0.66 (-0.13 %)
TLT $ 91.26 $ -1.24 (-1.36 %)
GLD $ 225.37 $ 0.39 (0.18 %)
$ 18.44
$ 18.44 x 200
$ 18.45 x 1,000
-- - --
$ 5.80 - $ 20.96
26,174,709
na
na
$ 1.31
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whos-who-at-the-benzinga-psychedelics-capital-conference-check-out-these-ceos--meet-them-in-person

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved i...

 benchmark-downgrades-trillium-therapeutics-to-hold

Benchmark analyst Aydin Huseynov downgrades Trillium Therapeutics (NASDAQ:TRIL) from Buy to Hold.

Core News & Articles

Trillium Therapeutics Inc. (“Trillium” or the “Company”) (TSX:TRIL), a clinical stage immuno-oncology company developing innova...

 craig-hallum-downgrades-trillium-therapeutics-to-hold-lowers-price-target-to-185

Craig-Hallum analyst Robin Garner downgrades Trillium Therapeutics (NASDAQ:TRIL) from Buy to Hold and lowers the price targe...

 60-biggest-movers-from-yesterday
60 Biggest Movers From Yesterday
08/24/2021 09:11:28

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed...

 jmp-securities-downgrades-trillium-therapeutics-to-market-perform

JMP Securities analyst Reni Benjamin downgrades Trillium Therapeutics (NASDAQ:TRIL) from Market Outperform to Market Perform.

 mid-afternoon-market-update-dow-gains-270-points-vivos-therapeutics-shares-spike-higher

Toward the end of trading Monday, the Dow traded up 0.77% to 35,392.00 while the NASDAQ rose 1.64% to 14,956.54. The S&P al...

 jim-cramer-thinks-more-acquisitions-from-pfizer-are-coming-reveals-what-similar-type-of-stocks-to-watch

Pfizer Inc. (NYSE: PFE) announced Monday that it entered into a definitive agreement to acquire Trillium Therapeutics Inc (NASD...

 mid-day-market-update-crude-oil-surges-5-staffing-360-solutions-shares-plunge

Midway through trading Monday, the Dow traded up 0.77% to 35,391.72 while the NASDAQ rose 1.35% to 14,912.95. The S&P also ...

 35-stocks-moving-in-mondays-mid-day-session

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by...

 benzingas-top-ratings-upgrades-downgrades-for-august-23-2021

Upgrades JP Morgan upgraded the previous rating for Pearson PLC (NYSE:PSO) from Neutral to Overweight. The current stock perf...

 mid-morning-market-update-markets-open-higher-pfizer-to-acquire-trillium-therapeutics

Following the market opening Monday, the Dow traded up 0.56% to 35,318.36 while the NASDAQ rose 0.90% to 14,847.67. The S&P...

 hc-wainwright--co-downgrades-trillium-therapeutics-to-neutral-lowers-price-target-to-185

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Trillium Therapeutics (NASDAQ:TRIL) from Buy to Neutral an...

Core News & Articles

    On Friday morning, 155 companies achieved new lows for the year.

 the-daily-biotech-pulse-jj-announces-ceo-transition-fibrogens-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION